ES2170654B1 - IMPROVEMENTS INTRODUCED IN THE OBJECT OF PATENT P9900757, BY A PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS. - Google Patents

IMPROVEMENTS INTRODUCED IN THE OBJECT OF PATENT P9900757, BY A PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS.

Info

Publication number
ES2170654B1
ES2170654B1 ES200000933A ES200000933A ES2170654B1 ES 2170654 B1 ES2170654 B1 ES 2170654B1 ES 200000933 A ES200000933 A ES 200000933A ES 200000933 A ES200000933 A ES 200000933A ES 2170654 B1 ES2170654 B1 ES 2170654B1
Authority
ES
Spain
Prior art keywords
humans
animals
gammaglobulins
obtaining
animal origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200000933A
Other languages
Spanish (es)
Other versions
ES2170654A1 (en
Inventor
Pozo Francisco J Polo
Canel Carmen Rodriguez
Navarro Jesus Rodenas
Martin Maria Nieves Saborido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APC Europe SA
Original Assignee
APC Europe SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APC Europe SA filed Critical APC Europe SA
Priority to EP00500066A priority Critical patent/EP1044690B1/en
Priority to AT00500066T priority patent/ATE300956T1/en
Priority to ES00500066T priority patent/ES2243223T3/en
Priority to DE60021644T priority patent/DE60021644D1/en
Publication of ES2170654A1 publication Critical patent/ES2170654A1/en
Application granted granted Critical
Publication of ES2170654B1 publication Critical patent/ES2170654B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Perfeccionamientos introducidos en el objeto de la Patente P9900757, por un procedimiento para la obtención de gammaglobulinas de origen animal y aplicaciones correspondientes, que consisten en una aplicación de una mezcla de proteínas plasmáticas con un contenido en gammaglobulina superior al 25% en peso para la preparación de composiciones medicamentosas, preparados alimenticios y dietéticos: [a] aptos para la prevención y tratamiento de enfermedades gastrointestinales en humanos y animales, [b] aptos para la mejora del estado inmunológico en humanos y animales, [c] aptos para el tratamiento de procesos de malabsorción en humanos y animales, y [d] aptos para el tratamiento de situaciones clínicas que cursan con desnutrición en humanos y animales.Improvements introduced in the object of Patent P9900757, by a method for obtaining gammaglobulins of animal origin and corresponding applications, which consist of an application of a mixture of plasma proteins with a gammaglobulin content exceeding 25% by weight for the preparation of medicinal compositions, food and dietary preparations: [a] suitable for the prevention and treatment of gastrointestinal diseases in humans and animals, [b] suitable for the improvement of the immune status in humans and animals, [c] suitable for the treatment of processes of malabsorption in humans and animals, and [d] suitable for the treatment of clinical situations that occur with malnutrition in humans and animals.

ES200000933A 1999-04-13 2000-04-11 IMPROVEMENTS INTRODUCED IN THE OBJECT OF PATENT P9900757, BY A PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS. Expired - Fee Related ES2170654B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00500066A EP1044690B1 (en) 1999-04-13 2000-04-12 Applications of gamma globulin-rich plasma protein mixtures of animal origin and process for the preparation thereof
AT00500066T ATE300956T1 (en) 1999-04-13 2000-04-12 APPLICATION AND PRODUCTION PROCESS OF ANIMAL GAMMAGLOBULIN-RICH PLASMA PROTEIN MIXTURES
ES00500066T ES2243223T3 (en) 1999-04-13 2000-04-12 APPLICATIONS OF MIXTURES OF PLASMATIC PROTEINS OF ANIMAL ORIGIN IN GAMMAGLOBULINES AND PROCEDURE FOR THEIR PREPARATION.
DE60021644T DE60021644D1 (en) 1999-04-13 2000-04-12 Application and method of preparation of animal gamma globulin-rich plasma protein mixtures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9900757A ES2158776B1 (en) 1999-04-13 1999-04-13 PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS.

Publications (2)

Publication Number Publication Date
ES2170654A1 ES2170654A1 (en) 2002-08-01
ES2170654B1 true ES2170654B1 (en) 2003-06-16

Family

ID=8308004

Family Applications (2)

Application Number Title Priority Date Filing Date
ES9900757A Expired - Fee Related ES2158776B1 (en) 1999-04-13 1999-04-13 PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS.
ES200000933A Expired - Fee Related ES2170654B1 (en) 1999-04-13 2000-04-11 IMPROVEMENTS INTRODUCED IN THE OBJECT OF PATENT P9900757, BY A PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES9900757A Expired - Fee Related ES2158776B1 (en) 1999-04-13 1999-04-13 PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS.

Country Status (1)

Country Link
ES (2) ES2158776B1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3272680D1 (en) * 1981-05-01 1986-09-25 Miles Lab Oral pharmaceutical composition containing immune globulin
DK166763B1 (en) * 1983-03-16 1993-07-12 Immuno Ag IMMUNOGLOBULIN-G-CONTAINING FRACTION
JP2672303B2 (en) * 1987-06-22 1997-11-05 財団法人 化学及血清療法研究所 Infection prevention and treatment for horses
JP2613409B2 (en) * 1987-11-20 1997-05-28 株式会社ミドリ十字 Method for producing anti-AIDS virus antibody-positive intravenous immunoglobulin preparation
EP0338229B1 (en) * 1988-04-19 1993-06-16 Biotest Pharma Gmbh Preparation with antibody activity and a large spectrum of action, remedy consisting of or containing it and its use for the treatment of bacterial or toxin-induced diseases and for combatting protozoa
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
ID27417A (en) * 1998-06-09 2001-04-05 Statens Seruminstitut PROCESS FOR PRODUCING IMMUNOGLOBULIN FOR GIVING THROUGH INTRAVENA AND OTHER IMMUNOGLOBULIN PRODUCTS

Also Published As

Publication number Publication date
ES2158776A1 (en) 2001-09-01
ES2170654A1 (en) 2002-08-01
ES2158776B1 (en) 2002-03-16

Similar Documents

Publication Publication Date Title
Yalcin Emerging therapeutic potential of whey proteins and peptides
MXPA05009933A (en) Compositions comprising fatty acids and amino acids.
PL1898724T3 (en) Infant nutrition with hydrolised proteins
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
HUP0200075A2 (en) Antioxidant compositions and methods for companion animals
BRPI0507482A (en) combination of (a) a dna topoisomerase inhibitor and (b) a iap inhibitor
WO2005082927A3 (en) Antihypertensive peptides
SE9804614D0 (en) New peptides and use thereof
MY149492A (en) Immunoglobulins directed against nogo
DK1661913T3 (en) Bioactive peptides derived from egg white protein through enzymatic hydrolysis
UA88165C2 (en) Use of trisubstituted benzopyranones
CY1108138T1 (en) USE OF LUPINOCONGLUTINE FOR TREATMENT OF DIABETES TYPE II
AR035652A1 (en) A NUTRITIONAL COMPOSITION, USEFUL TO COMBAT INFECTION IN THE GASTROINTESTINAL TRACT CAUSED BY HELICOBACTER TYPE ORGANISMS, THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF MEDICINES, OR FOOD PRODUCTS AND THE PROCEDURE TO PREPARE SUCH COMPOSITION
DE60012301D1 (en) LIPOPROTEIN COMPLEXES AND COMPOSITIONS CONTAINING THEM
WO2004039326A3 (en) Propofol with cysteine
DE60218636D1 (en) ANTIBODIES FOR THE PREVENTION AND TREATMENT OF E. COLI AEEC DISEASES
BR0313031A (en) Spicy particle, food product, process for the preparation of a particle and use of a spicy particle
MX2007004104A (en) Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress.
WO2004006830A3 (en) Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
DE602004005821D1 (en) ENTERAL PREPARATION FOR PREVENTING BZW. TREATMENT OF SEPSIS
MXPA06002648A (en) Milk fractions and milk preparations for treating and/or preventing cox-2 mediated diseases.
ES2170654B1 (en) IMPROVEMENTS INTRODUCED IN THE OBJECT OF PATENT P9900757, BY A PROCEDURE FOR OBTAINING GAMMAGLOBULINS OF ANIMAL ORIGIN AND CORRESPONDING APPLICATIONS.
ATE458004T1 (en) OSTEOPROTEGERIN IN MILK
HUP0204209A2 (en) Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
ATE499093T1 (en) CITICOLINE-BASED COMPOSITION IN COMBINATION WITH VITAMINS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020801

Kind code of ref document: A1

Effective date: 20020801

FG2A Definitive protection

Ref document number: 2170654B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312